Comparative evaluation of nasopharyngeal swab and saliva specimens for the molecular detection of SARS-CoV-2 RNA in Japanese patients with COVID-19
- PMID: 33060046
- PMCID: PMC7524660
- DOI: 10.1016/j.jiac.2020.09.027
Comparative evaluation of nasopharyngeal swab and saliva specimens for the molecular detection of SARS-CoV-2 RNA in Japanese patients with COVID-19
Abstract
Considering the issues of shortage of medical resources and the invasiveness and infection risk involved in the collection of nasopharyngeal swab specimens, there is a need for an effective alternative test specimen for SARS-CoV-2 RNA detection. Here, we investigated suitability of saliva as a non-invasively obtained specimen for molecular detection of SARS-CoV-2 RNA in Japanese patients with COVID-19. In total, 28 paired clinical specimens of saliva and nasopharyngeal swabs were collected from 12 patients at various time points after symptom onset. Each specimen was assayed using reverse transcription real-time polymerase chain reaction (rRT-PCR) on the BD MAX open system using primers and probes targeting the N-gene. The saliva and nasopharyngeal swab specimens showed 19 and 15 positive results, respectively. No invalid (PCR inhibition) result was observed for any specimen. The qualitative results of each specimen obtained in the period immediately after symptom onset were similar. Three convalescent patients presented saliva-positive results, whereas their nasopharyngeal swabs were negative at four different time points, suggesting that saliva may be superior to nasopharyngeal swabs in terms of obtaining stable assay result of SARS-CoV-2. In conclusion, our results suggest that saliva can potentially serve as an alternative to nasopharyngeal swabs as a specimen for SARS-CoV-2 rRT-PCR. As saliva can be collected by patients themselves, it may be an effective way to overcome the shortage of personal protective equipment and specimen sampling tools.
Keywords: Nasopharyngeal swab; Reverse transcription real-time PCR; SARS-CoV-2; Saliva.
Copyright © 2020 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of competing interest H. Mikamo has received grant support from Asahi Kasei Pharma Corporation, Shionogi & Co. Ltd., Daiichi Sankyo Co., Ltd., Sumitomo Dainippon Pharma Co., Ltd., Pfizer Japan Inc. and FUJIFILM Toyama Chemical Co., Ltd., payment for lectures from Astellas Pharma Inc., MSD K.K., Daiichi Sankyo Co., Ltd., Sumitomo Dainippon Pharma Co., Ltd., MIYARISAN Pharmaceutical Co., Ltd. Becton, Dickinson and Company Japan, and FUJIFILM Toyama Chemical Co. Ltd. The other authors declare that they have no conflicts of interest.
Figures


Similar articles
-
Evaluation of simple nucleic acid extraction methods for the detection of SARS-CoV-2 in nasopharyngeal and saliva specimens during global shortage of extraction kits.J Clin Virol. 2020 Aug;129:104519. doi: 10.1016/j.jcv.2020.104519. Epub 2020 Jun 23. J Clin Virol. 2020. PMID: 32629187 Free PMC article.
-
Value of swab types and collection time on SARS-COV-2 detection using RT-PCR assay.J Virol Methods. 2020 Dec;286:113974. doi: 10.1016/j.jviromet.2020.113974. Epub 2020 Sep 16. J Virol Methods. 2020. PMID: 32949663 Free PMC article.
-
A Direct Comparison of Enhanced Saliva to Nasopharyngeal Swab for the Detection of SARS-CoV-2 in Symptomatic Patients.J Clin Microbiol. 2020 Oct 21;58(11):e01946-20. doi: 10.1128/JCM.01946-20. Print 2020 Oct 21. J Clin Microbiol. 2020. PMID: 32883744 Free PMC article.
-
New COVID-19 saliva-based test: How good is it compared with the current nasopharyngeal or throat swab test?J Chin Med Assoc. 2020 Oct;83(10):891-894. doi: 10.1097/JCMA.0000000000000396. J Chin Med Assoc. 2020. PMID: 32773584 Free PMC article. Review.
-
Upper respiratory tract sampling in COVID-19.Malays J Pathol. 2020 Apr;42(1):23-35. Malays J Pathol. 2020. PMID: 32342928 Review.
Cited by
-
ESCMID COVID-19 guidelines: diagnostic testing for SARS-CoV-2.Clin Microbiol Infect. 2022 Jun;28(6):812-822. doi: 10.1016/j.cmi.2022.02.011. Epub 2022 Feb 23. Clin Microbiol Infect. 2022. PMID: 35218978 Free PMC article.
-
Viral RNA Load and Infectivity of SARS-CoV-2 in Paired Respiratory and Oral Specimens from Symptomatic, Asymptomatic, or Postsymptomatic Individuals.Microbiol Spectr. 2022 Jun 29;10(3):e0226421. doi: 10.1128/spectrum.02264-21. Epub 2022 May 16. Microbiol Spectr. 2022. PMID: 35575498 Free PMC article.
-
Sensitive extraction-free SARS-CoV-2 RNA virus detection using a novel RNA preparation method.medRxiv [Preprint]. 2021 Feb 1:2021.01.29.21250790. doi: 10.1101/2021.01.29.21250790. medRxiv. 2021. Update in: iScience. 2021 Sep 24;24(9):102960. doi: 10.1016/j.isci.2021.102960. PMID: 33532808 Free PMC article. Updated. Preprint.
-
Quantitative and Ultrasensitive In-situ Immunoassay Technology for SARS-CoV-2 Detection in Saliva.Res Sq [Preprint]. 2021 Jan 18:rs.3.rs-138025. doi: 10.21203/rs.3.rs-138025/v1. Res Sq. 2021. Update in: Sci Adv. 2022 May 27;8(21):eabn3481. doi: 10.1126/sciadv.abn3481. PMID: 33469572 Free PMC article. Updated. Preprint.
-
SARS-COV-2 detection in saliva and nasopharyngeal swabs using RT-PCR was similar.Braz Dent J. 2022 Mar-Apr;33(2):68-72. doi: 10.1590/0103-6440202204591. Braz Dent J. 2022. PMID: 35508038 Free PMC article.
References
-
- Ministry of Health, Labour and Welfare Japan About coronavirus disease. 2019. https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/newpage_00032.html
-
- National Institute of Infectious Diseases Japan nCoV (new coronavirus) Sample collection and transportation manual. 2019. https://www.niid.go.jp/niid/images/pathol/pdf/2019-nCoV_200416.pdf.Japanese ver. 16 April 2020.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous